SynthesisBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2021

Systematic Review and Principal Components Analysis of the Immunogenicity of Adalimumab.

Rodrigo Borrega et al.PubMed ↗Publisher ↗

No numbers read from the abstract.